BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38061922)

  • 1. Association between remnant cholesterol and incident atherosclerotic cardiovascular disease, heart failure, and atrial fibrillation.
    Tada H; Kaneko H; Suzuki Y; Okada A; Takeda N; Fujiu K; Morita H; Ako J; Node K; Takeji Y; Takamura M; Yasunaga H; Komuro I
    J Clin Lipidol; 2024; 18(1):3-10. PubMed ID: 38061922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial hypercholesterolemia is related to cardiovascular disease, heart failure and atrial fibrillation. Results from a population-based study.
    Tada H; Kaneko H; Suzuki Y; Okada A; Takeda N; Fujiu K; Morita H; Ako J; Node K; Takeji Y; Takamura M; Yasunaga H; Komuro I
    Eur J Clin Invest; 2024 Feb; 54(2):e14119. PubMed ID: 37916502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.
    Quispe R; Martin SS; Michos ED; Lamba I; Blumenthal RS; Saeed A; Lima J; Puri R; Nomura S; Tsai M; Wilkins J; Ballantyne CM; Nicholls S; Jones SR; Elshazly MB
    Eur Heart J; 2021 Nov; 42(42):4324-4332. PubMed ID: 34293083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of Serum Uric Acid and Cardiovascular Events in Young Adults Aged 20-49 Years.
    Seki H; Kaneko H; Morita H; Itoh H; Morita K; Matsuoka S; Kiriyama H; Kamon T; Fujiu K; Michihata N; Jo T; Takeda N; Yano Y; Nakamura S; Node K; Yasunaga H; Komuro I
    Am J Cardiol; 2021 Aug; 152():150-157. PubMed ID: 34140140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-Year Risk Equations for Incident Heart Failure in Established Atherosclerotic Cardiovascular Disease Populations.
    Dawson LP; Carrington MJ; Haregu T; Nanayakkara S; Jennings G; Dart A; Stub D; Inouye M; Kaye D
    J Am Heart Assoc; 2024 Jun; 13(11):e034254. PubMed ID: 38780153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation.
    Kaneko H; Yano Y; Itoh H; Morita K; Kiriyama H; Kamon T; Fujiu K; Michihata N; Jo T; Takeda N; Morita H; Node K; Carey RM; Lima JAC; Oparil S; Yasunaga H; Komuro I
    Circulation; 2021 Jun; 143(23):2244-2253. PubMed ID: 33886370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease.
    Xiao Z; Lin Z; Xu L; Xu W; Huang H; Wang Y; Cao S; Xie Z; Liao W; Liao Y; Bin J; Feng W; Chen Y
    Eur J Prev Cardiol; 2023 Nov; 30(17):1924-1934. PubMed ID: 37708385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of resistin with cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis.
    Muse ED; Feldman DI; Blaha MJ; Dardari ZA; Blumenthal RS; Budoff MJ; Nasir K; Criqui MH; Cushman M; McClelland RL; Allison MA
    Atherosclerosis; 2015 Mar; 239(1):101-8. PubMed ID: 25585029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid levels in midlife and risk of atrial fibrillation over 3 decades-Experience from the Swedish AMORIS cohort: A cohort study.
    Ding M; Wennberg A; Gigante B; Walldius G; Hammar N; Modig K
    PLoS Med; 2022 Aug; 19(8):e1004044. PubMed ID: 35951514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes in heart failure patients with and without atrial fibrillation receiving sodium-glucose cotransporter-2 inhibitor.
    Hu WS; Lin CL
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):1977-1986. PubMed ID: 36881169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Electrocardiographic Age and Cardiovascular Events in Community Settings: The Framingham Heart Study.
    Brant LCC; Ribeiro AH; Pinto-Filho MM; Kornej J; Preis SR; Fetterman JL; Eromosele OB; Magnani JW; Murabito JM; Larson MG; Benjamin EJ; Ribeiro ALP; Lin H
    Circ Cardiovasc Qual Outcomes; 2023 Jul; 16(7):e009821. PubMed ID: 37381910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study.
    Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
    Diabetologia; 2023 Dec; 66(12):2238-2249. PubMed ID: 37776347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL₃+IDL]).
    May HT; Nelson JR; Kulkarni KR; Anderson JL; Horne BD; Bair TL; Muhlestein JB
    Lipids Health Dis; 2013 Apr; 12():55. PubMed ID: 23621905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
    Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C
    Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
    Castañer O; Pintó X; Subirana I; Amor AJ; Ros E; Hernáez Á; Martínez-González MÁ; Corella D; Salas-Salvadó J; Estruch R; Lapetra J; Gómez-Gracia E; Alonso-Gomez AM; Fiol M; Serra-Majem L; Corbella E; Benaiges D; Sorli JV; Ruiz-Canela M; Babió N; Sierra LT; Ortega E; Fitó M
    J Am Coll Cardiol; 2020 Dec; 76(23):2712-2724. PubMed ID: 33272365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of retinal atherosclerosis assessed using Keith-Wagener-Barker system with incident heart failure and other atherosclerotic cardiovascular disease: Analysis of 319,501 individuals from the general population.
    Matsuoka S; Kaneko H; Okada A; Itoh H; Suzuki Y; Fujiu K; Michihata N; Jo T; Takeda N; Morita H; Nakamura S; Node K; Yasunaga H; Komuro I
    Atherosclerosis; 2022 May; 348():68-74. PubMed ID: 35292151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incident Clinical and Mortality Associations of Myocardial Native T1 in the UK Biobank.
    Raisi-Estabragh Z; McCracken C; Hann E; Condurache DG; Harvey NC; Munroe PB; Ferreira VM; Neubauer S; Piechnik SK; Petersen SE
    JACC Cardiovasc Imaging; 2023 Apr; 16(4):450-460. PubMed ID: 36648036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign Prostatic Hyperplasia and Incident Cardiovascular Disease.
    Suzuki Y; Kaneko H; Okada A; Fujiu K; Jo T; Takeda N; Tanaka A; Node K; Morita H; Yasunaga H; Komuro I
    Circ J; 2024 Feb; 88(3):408-416. PubMed ID: 38246651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.